Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8099 USD | +10.04% | -7.79% | +12.96% |
Apr. 26 | VolitionRx Limited Announces Board Changes | CI |
Apr. 23 | VolitionRx Limited Launches In-Clinic in U.S. and Europe Through Antech | CI |
Financials (USD)
Sales 2024 * | 3.63M | Sales 2025 * | 16.48M | Capitalization | 60.43M |
---|---|---|---|---|---|
Net income 2024 * | -36M | Net income 2025 * | -32M | EV / Sales 2024 * | 14.2 x |
Net cash position 2024 * | 8.9M | Net Debt 2025 * | 18.4M | EV / Sales 2025 * | 4.78 x |
P/E ratio 2024 * |
-1.81
x | P/E ratio 2025 * |
-2.28
x | Employees | 110 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.1% |
Latest transcript on VolitionRx Limited
1 day | +10.04% | ||
1 week | -7.79% | ||
Current month | -10.00% | ||
1 month | +10.79% | ||
3 months | -28.33% | ||
6 months | -7.98% | ||
Current year | +12.96% |
Managers | Title | Age | Since |
---|---|---|---|
Cameron Reynolds
CEO | Chief Executive Officer | 53 | 11-10-05 |
Terig Hughes
DFI | Director of Finance/CFO | 54 | 21-01-31 |
Gaetan Michel
COO | Chief Operating Officer | 51 | 21-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cameron Reynolds
CEO | Chief Executive Officer | 53 | 11-10-05 |
Martin Faulkes
CHM | Chairman | 80 | 11-10-05 |
Guy Innes
BRD | Director/Board Member | 67 | 11-10-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 0.8099 | +10.04% | 164,072 |
24-05-08 | 0.736 | +2.22% | 174,260 |
24-05-07 | 0.72 | -7.61% | 304,804 |
24-05-06 | 0.7793 | -12.53% | 182,092 |
24-05-03 | 0.8909 | +1.43% | 108,909 |
Delayed Quote Nyse, May 09, 2024 at 04:10 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.96% | 60.43M | |
-26.80% | 10.94B | |
+65.44% | 3.75B | |
-28.13% | 2.27B | |
-10.06% | 2.25B | |
-25.01% | 1.54B | |
+50.53% | 1.18B | |
-2.84% | 754M | |
-7.83% | 529M | |
-27.35% | 469M |
- Stock Market
- Equities
- VNRX Stock